Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Red blood cells |White blood cells |Lymphocytes |Platelets |Cryoprecipitate |Fresh Frozen Plasma |Blood Cell Maturation
๐ฉธ Cryoprecipitate refers to the proteins that precipitate out of Fresh Frozen Plasma (FFP) when thawed slowly. It contains fibrinogen, factor VIII, von Willebrand factor (vWF), and fibronectin. Its primary use is to raise fibrinogen levels in the blood, particularly in bleeding or consumptive coagulopathies.
| Characteristic | Fresh Frozen Plasma (FFP) | Cryoprecipitate (Cryo) |
|---|---|---|
| Composition | Contains all clotting factors, fibrinogen, albumin, immunoglobulins, other plasma proteins | Rich in fibrinogen, Factor VIII, vWF, Factor XIII, fibronectin |
| Volume | 200โ300 mL/unit | 10โ20 mL/unit (usually pooled in 5โ10 packs) |
| Storage | โ25 ยฐC up to 1 year. Once thawed โ use within 24 hrs if refrigerated. | โ25 ยฐC up to 1 year. Once thawed โ use within 6 hrs. |
| Primary Use | Broad replacement of clotting factors (coagulopathy, liver disease, warfarin reversal) | Specific to hypofibrinogenemia & Factor XIII deficiency |
| Indications |
|
|
| Contraindications |
|
|
| Dosing | 10โ15 mL/kg (โ3โ4 units in adult) | 10 units raises fibrinogen ~0.7 g/L |